764
Views
16
CrossRef citations to date
0
Altmetric
Review

Emerging biological therapies to treat acute lymphoblastic leukemia

&
Pages 107-121 | Received 22 Jul 2016, Accepted 02 Nov 2016, Published online: 25 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (15)

Yusi Zhou, Yang Su, Yutong Xu & Ming Shi. (2023) Editorial: Immunotherapy for hematological malignancies in children. Frontiers in Pediatrics 11.
Crossref
Jiao Xie, Suxiang Liu, Ming Zhou, Yi Wang, Hailong He, Peifang Xiao, Shaoyan Hu & Jun Lu. (2023) Short-course blinatumomab for refractory/relapse precursor B acute lymphoblastic leukemia in children. Frontiers in Pediatrics 11.
Crossref
Benjamin Micallef, Robert Nistico, Ole Weis Bjerrum, Sinan Bardakci Sarac, Dianne Butler, Anthony Serracino-Inglott & John-Joseph Borg. (2022) Outcomes and endpoints in clinical trials supporting the marketing authorisation of treatments in paediatric acute lymphoblastic leukaemia. Drug Discovery Today 27:9, pages 2440-2466.
Crossref
Fang-Liang Huang, Sheng-Jie Yu & Chia-Ling Li. (2021) Role of Autophagy and Apoptosis in Acute Lymphoblastic Leukemia. Cancer Control 28, pages 107327482110191.
Crossref
Romeo G. Mihăilă. (2020) Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology. Recent Patents on Anti-Cancer Drug Discovery 15:4, pages 272-292.
Crossref
Sylwia Jasinski, Francis Andrew De Los Reyes, Gloria Contreras Yametti, Joanna Pierro, Elizabeth Raetz & William L. Carroll. (2020) Immunotherapy in Pediatric B-Cell Acute Lymphoblastic Leukemia: Advances and Ongoing Challenges. Pediatric Drugs 22:5, pages 485-499.
Crossref
Patrick J. Engelberts, Ida H. Hiemstra, Bart de Jong, Danita H. Schuurhuis, Joyce Meesters, Irati Beltran Hernandez, Simone C. Oostindie, Joost Neijssen, Edward N. van den Brink, G. Jean Horbach, Sandra Verploegen, Aran F. Labrijn, Theodora Salcedo, Janine Schuurman, Paul W.H.I Parren & Esther C.W. Breij. (2020) DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing. EBioMedicine 52, pages 102625.
Crossref
Josiah D. Smith, Leah N. Cardwell, David Porciani, Andrea Nolla, Brenna T. Cornelison, Megan C. Schulte, Fabio Gallazzi, Donald H. Burke, Mark A. Daniels & Bret D. Ulery. (2020) Therapeutic peptide delivery via aptamer-displaying, disulfide-linked peptide amphiphile micelles . Molecular Systems Design & Engineering 5:1, pages 269-283.
Crossref
Shipra Gandhi, Aman Gupta & Marc S. Ernstoff. 2020. Handbook of Cancer Treatment-Related Symptons and Toxicities. Handbook of Cancer Treatment-Related Symptons and Toxicities 201 222 .
Tamas Fulop, Jacek M. Witkowski, K. Hirokawa, A. Larbi & G. Pawelec. 2020. Geriatric Oncology. Geriatric Oncology 71 90 .
A Ślifirczyk, P. Piszcz, M. Ślifirczyk, T. Michalczuk, M. Urbańczuk, M. Celiński, M. Bytys, D. Domańska & M. Nikoniuk. (2018) Nursing care of a child with acute lymphoblastic leukemia. Progress in Health Sciences 8:2, pages 168-173.
Crossref
Josiah D Smith, Leah N Cardwell, David Porciani, Julie A Nguyen, Rui Zhang, Fabio Gallazzi, Rama Rao Tata, Donald H Burke, Mark A Daniels & Bret D Ulery. (2018) Aptamer-displaying peptide amphiphile micelles as a cell-targeted delivery vehicle of peptide cargoes. Physical Biology 15:6, pages 065006.
Crossref
Tamas Fulop, J. M. Witkowski, K. Hirokawa, A. Larbi & G. Pawelec. 2018. Geriatric Oncology. Geriatric Oncology 1 20 .
Brent A. Williams, Arjun Datt Law, Bertrand Routy, Neal denHollander, Vikas Gupta, Xing-Hua Wang, Amélie Chaboureau, Sowmya Viswanathan & Armand Keating. (2017) A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy. Oncotarget 8:51, pages 89256-89268.
Crossref
Monika Barełkowska & Katarzyna Derwich. 2017. Unique Aspects of Anti-cancer Drug Development. Unique Aspects of Anti-cancer Drug Development.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.